Linked Life Data

18405787

Source:http://linkedlifedata.com/resource/pubmed/id/18405787

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18405787rdf:typepubmed:Citationlld:pubmed
pubmed-article:18405787lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0232804lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0014025lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0051696lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18405787lifeskim:mentionsumls-concept:C0599724lld:lifeskim
pubmed-article:18405787pubmed:issue3lld:pubmed
pubmed-article:18405787pubmed:dateCreated2008-4-14lld:pubmed
pubmed-article:18405787pubmed:abstractTextPlacebo-controlled trials have found that angiotensin-converting enzyme inhibitors (ACEIs) decrease proteinuria and slow the progression of nondiabetic nephropathies. However, head-to-head comparisons of ACEIs and calcium channel blockers (CCBs) have shown conflicting results. Indeed, a recent metaanalysis concluded that there is still uncertainty about the greater renoprotection seen with ACEIs or angiotensin II receptor blockers in nondiabetic patients with renal disease, particularly when using true glomerular filtration rate (GFR) as the primary outcome.lld:pubmed
pubmed-article:18405787pubmed:languageenglld:pubmed
pubmed-article:18405787pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:citationSubsetIMlld:pubmed
pubmed-article:18405787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18405787pubmed:statusMEDLINElld:pubmed
pubmed-article:18405787pubmed:monthMarlld:pubmed
pubmed-article:18405787pubmed:issn0149-2918lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:CalvoCarlosClld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:ApetreiEduard...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:BrownEdwina...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:HoldaasHallva...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:EsnaultVincen...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:KobalavaZhann...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:KrcmerySilves...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:BagonJacquesJlld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:DeChatelRudol...lld:pubmed
pubmed-article:18405787pubmed:authorpubmed-author:Amlodipine...lld:pubmed
pubmed-article:18405787pubmed:issnTypePrintlld:pubmed
pubmed-article:18405787pubmed:volume30lld:pubmed
pubmed-article:18405787pubmed:ownerNLMlld:pubmed
pubmed-article:18405787pubmed:authorsCompleteYlld:pubmed
pubmed-article:18405787pubmed:pagination482-98lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:meshHeadingpubmed-meshheading:18405787...lld:pubmed
pubmed-article:18405787pubmed:year2008lld:pubmed
pubmed-article:18405787pubmed:articleTitleThe effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.lld:pubmed
pubmed-article:18405787pubmed:affiliationPasteur Hospital, Université de Nice-Sofia Antipolis, Nice, France. esnault.v@chu-nice.frlld:pubmed
pubmed-article:18405787pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18405787pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18405787pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18405787pubmed:publicationTypeMulticenter Studylld:pubmed